These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 395077)

  • 1. Continuous intravenous insulin therapy with a miniaturized open-loop system.
    Renner R; Hepp KD; Mehnert H; Franetzki M
    Horm Metab Res Suppl; 1979; (8):186-90. PubMed ID: 395077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Closed-loop system in evaluation of insulin infusion rates for an open-loop system.
    Kølendorf K; Christiansen JS; Svendsen PA; Bojsen J
    Horm Metab Res Suppl; 1979; (8):205-6. PubMed ID: 395082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of a perfusion syringe (Mill Hill Infusor) and a glucose-controlled insulin infusion system in the regulation of diabetes mellitus.
    Stavljenić A; Granić M; Topić B; Skrabalo Z
    Horm Metab Res Suppl; 1979; (8):207-11. PubMed ID: 395083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimal blood sugar control in labile diabetics using a portable open-loop insulin infusion system with a flexible program.
    Froesch ER; Blatter G; Morell B
    Horm Metab Res Suppl; 1979; (8):198-201. PubMed ID: 395079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A portable, pre-programmable insulin infusion system in diabetes mellitus.
    Kølendorf K; Bojsen J
    Horm Metab Res Suppl; 1979; (8):191-3. PubMed ID: 395078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of glucose-controlled insulin infusion system for improvement of subcutaneous insulin regimen.
    Irsigler K; Kritz H; Kaspar L; Brändle J; Franetzki M
    Horm Metab Res Suppl; 1979; (8):134-40. PubMed ID: 395070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical application of pre-programmed insulin infusion: continuous subcutaneous insulin therapy with a portable infusion system.
    Pickup JC; Viberti GC; Keen H; Parsons JA; Alberti KG
    Horm Metab Res Suppl; 1979; (8):202-4. PubMed ID: 395081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin treatment and state of control before, during, and after connection to a glucose controlled insulin infusion system (Biostator).
    Christiansen JS; Svendsen PA; Deckert T
    Horm Metab Res Suppl; 1979; (8):131-4. PubMed ID: 395069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The external artificial pancreas: an instrument to induce remissions in severe recent juvenile diabetes. Comparison with a preprogrammed insulin infusion system.
    Mirouze J; Selam JL; Pham TC; Orsetti A
    Horm Metab Res Suppl; 1979; (8):141-5. PubMed ID: 395071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a closed-loop artificial pancreas.
    Kraegen EW; Whiteside R; Bell D; Chia YO; Lazarus L
    Horm Metab Res Suppl; 1979; (8):38-42. PubMed ID: 395087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fully automated closed-loop insulin delivery versus semiautomated hybrid control in pediatric patients with type 1 diabetes using an artificial pancreas.
    Weinzimer SA; Steil GM; Swan KL; Dziura J; Kurtz N; Tamborlane WV
    Diabetes Care; 2008 May; 31(5):934-9. PubMed ID: 18252903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preprogrammed insulin infusion with a portable pump system.
    Irsigler K; Kritz H; Kaspar L; Brändle J; Koller W; Franetzki M
    Horm Metab Res Suppl; 1979; (8):193-7. PubMed ID: 119699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of insulin infusion kinetics of an artificial beta cell on blood glucose control in insulin-dependent diabetics.
    Kerner W; Beischer W; Maier V; Pfeiffer EF
    Horm Metab Res Suppl; 1979; (8):71-80. PubMed ID: 395094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Improvement in the treatment of diabetes by means of a portable insulin-infusion apparatus. Preliminary results in 4 unstable juvenile diabetics].
    Porr O; Morell B; Walter H; Sturzenegger J; Froesch ER
    Schweiz Med Wochenschr; 1980 Nov; 110(47):1761-3. PubMed ID: 7006076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of three days of blood glucose normalization by means of an "artificial endocrine pancreas" on the concentrations of growth hormone, glucagon, and cortisol in juvenile diabetics.
    Schock A; Schultz M; Kerner W; Maier V; Pfeiffer EF
    Horm Metab Res Suppl; 1979; (8):93-6. PubMed ID: 395097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of 24-hour insulin infusion pattern by an artificial endocrine pancreas for intravenous insulin infusion with a miniature pump.
    Kølendorf K; Christiansen JS; Bojsen J; Svendsen PA; Teglbjaerg LL
    Horm Metab Res; 1981 May; 13(5):245-9. PubMed ID: 7021384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A portable, Preprogrammable insulin infusion system with 16 rates.
    Kølendorf K; Bojsen J
    Horm Metab Res Suppl; 1979; (8):65-6. PubMed ID: 395092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Control algorithms for artificial beta cell.
    Clemens AH
    Horm Metab Res Suppl; 1979; (8):35-8. PubMed ID: 395086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The artificial beta cell (Biostator) in the adjustment of instable diabetics--results after 20 months.
    Beyer J; Wolf E; Cordes U; Hassingen W
    Horm Metab Res Suppl; 1979; (8):127-31. PubMed ID: 395068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A portable infusion pump, programmable with 16 rates.
    Bojsen J; Kølendorf K; Haslev F; Jørgensen K
    Biotelem Patient Monit; 1978; 5(3):123-33. PubMed ID: 754819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.